GamaMabs Pharma

GamaMabs Pharma

GamaMabs Pharma

GamaMabs Pharmais a biotechnology firm engaged in the development of a new therapeutic antibody for the treatment of ovarian cancer.
Founded
2013
Raised
$21.8M
Follow us
Alexa global traffic share
30 Sep 2013
$3,988,460
Venture capital